Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyrimethamine in Familial ALS
NCT01083667Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Nov 2009
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of pyrimethamine in familial amyotrophic lateral sclerosis (FALS), sponsored by Weill Cornell Medicine. Started Nov 2009; status: completed.
02
Drugs
pyrimethamine
03
Conditions
familial amyotrophic lateral sclerosis (FALS)
Beyond the preview
Go deeper on NCT01083667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01083667.